Opposing roles of mGluR8 in measures of anxiety involving non-social and social challenges

Behavioural Brain Research

Volumn 221, Issue 1, 2011, Pages 50-54

  Duvoisin, Robert M ^a   Villasana, Laura ^b   Davis, Matthew J ^b   Winder, Danny G ^c,d   Raber, Jacob ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acoustic startle; Allosteric modulator; Group III mGluR; Metabotropic; Social interaction; Zero maze

Indexed keywords

AZ 12216052; METABOTROPIC RECEPTOR 4; METABOTROPIC RECEPTOR 8; METABOTROPIC RECEPTOR AGONIST; UNCLASSIFIED DRUG; VU 0155041;

AGED; AGING; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SOCIAL INTERACTION; STARTLE REFLEX; TRANQUILIZING ACTIVITY; WILD TYPE;

ACETANILIDES; AGING; ANILIDES; ANIMALS; ANXIETY; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERPERSONAL RELATIONS; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, METABOTROPIC GLUTAMATE; SENSORY GATING; THIOGLYCOLATES;

EID: 79952840690     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.02.049     Document Type: Article

References (31)

1. Pin J.P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology 1995, 34:1-26.
2. Conn P.J., Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997, 37:205-237.
3. Duvoisin R.M., Zhang C., Ramonell K. A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. J Neurosci 1995, 15:3075-3083.
4. Saugstad J.A., Kinzie J.M., Shinohara M.M., Segerson T.P., Westbrook G.L. Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Mol Pharmacol 1997, 51:119-125.
5. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 2000, 75:889-907.
6. Niswender C., Conn P.J. Metbotropic glutamate receptors: physiology, pharmacology, and disease. Pharmacol Toxicol 2010, 50:295-322.
7. Linden A.M., Johnson B.G., Peters S.C., Shannon H.E., Tian M., Wang Y., et al. Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor. Neuropharmacology 2002, 43:251-259.
8. Duvoisin R., Zhang C., Pfankuch T., O'Connor H., Gayet-Primo J., Quraishi S., et al. Increased measures of anxiety and weight gain in mice lacking the group III metabotropic glutamate receptor mGluR8. Eur J Neurosci 2005, 1-13.
9. Duvoisin R., Villasana L., Pfankuch T., Raber J. Sex-dependent cognitive phenotype of mice lacking mGluR8. Beh Brain Res 2010, 209:21-26.
10. Fendt M., Burki H., Imobersteg S., van der Putten H., McAllister K., Leslie J., et al. The effect of mGlu8 deficiency in animal models of psychiatric disease. Genes Brain Behav 2010, 9:33-44.
11. Duvoisin R., Pfankuch T., Wilson J., Grabell J., Chhajlani V., Brown D., et al. Acute pharmacological modulation of mGluR8 reduces measures of anxiety. Beh Brain Res 2010, 212:168-173.
12. Ramanathan M., Jaiswal A., Bhattacharya S. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology 1998, 135:361-367.
13. Bilkei-Gorzo A., Racz I., Michel K., Zimmer A. Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 2002, 22:10046-10052.
14. Kwon C.-H., Luikart B., Powell C., Zhou J., Matheny S., Zhang W., et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006, 50:377-388.
15. Liu Z., Smitch C. Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndrome. Neurosci Lett 2009, 17:62-66.
16. Egashira N., Tanoue A., Matsuda T., Koushi E., Harada S., Takano Y., et al. Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Beh Brain Res 2007, 178:123-127.
17. Deacon R., Bannerman D., Rawlins J. Anxiolytic effects of cytotoxic hippoampla lesions in rats. Behav Neurosci 2002, 116:494-497.
18. Salchner P., Luec G., Singewald N. Decreased social interaction in aged rats may not reflect changes in anxiety-related behaviour. Beh Brain Res 2004, 151:108.
19. Kathuria S., Gaetani S., Fegley D., Valino F., Duranti A., Tontine A., et al. Modulation of anxiety trough blockade of anandamide hydrolysis. Nat Med 2002, 9:76-81.
20. Rahn E., Zvonok A., Thakur G., Khalnolkar A., Makriyanic A., Hohman A. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agen paclitaxel in rats. J Pharmaco Exp Ther 2008, 327:584-591.
21. Malan T., Ibrahim M., Deng H., Lin Q., Mata H., Vanderah T., et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001, 93:239-245.
22. Ibrahim M., Porreca F., Lai J., Albrecht P., Rice F., Khodorova A., et al. CB2 cannboid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Nat Acad Sci USA 2005, 102:3093-3098.
23. Fossum E., Lisowski M., Macey T., Ingram S., Morgan S. Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaquaductal gray modulates morphine nociception. Brain Res 2008, 1204:53-58.
24. Niswender C.M., Johnson K.A., Weaver C.D., Jones C.K., Xiang Z., Luo Q., et al. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4. Mol Pharmacol 2008, 74:1345-1358.
25. Benice T., Rizk A., Pfankuch T., Kohama S., Raber J. Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006, 137:413-423.
26. Dorsa D.M., Petracca F.M., Baskin D.G., Cornett L.E. Localization and characterization of vasopressin binding sites in the amygdala of the rat brain. J Neurosci 1984, 4:1764-1770.
27. Rizk A., Curley J., Robertson J., Raber J. Anxiety and cognition in histamine H3 receptor-/- mice. Eur J Neurosci 2004, 19:1992-1996.
28. Kaschka W., Feistel H., Ebert D. Reduced benzodiazepine receptor binding in panic disorder measured by iomazenil SPECT. J Psychiatr Res 1995, 29:427-434.
29. Roy-Byrne P., Wingerson D., Radant A., Greenblatt D., Cowley D. Reduced benzodiazepine sensitivity in patients with panic disorder: comparison with patients with obsessive-compulsive disorder and normal subjects. Am J Psychiatr 1996, 153:1444-1449.
30. Schlegel S., Steinert H., Bockisch A., Hahn K., Schloesser R., Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report. Eur Arch Psychiatry Clin Neurosci. 1994, 244:49-51.
31. Sundstrom I., Ashbrook D., Backstrom T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 1997, 22:25-38.